Africa accounts for 15% of the global population and 25% of the global disease burden, yet the discovery and development of medicines that end up in Africa has historically only happened in the global north. It is time for the situation to change, says Professor Kelly Chibale, director and founder of the University of Cape Town’s (UCT) Drug Discovery and Development Centre, H3D.
The 10-kilometre peace run in aid of the Weekend Waiting List Initiative at Red Cross War Memorial Children’s Hospital has raised more than R200 000 for the worthy programme, far surpassing the target of R150 000.
An international, collaborative study involving University of Cape Town (UCT) researchers has revealed an unexpected finding that could lead to better therapies towards reducing the HIV reservoir, a major barrier to developing a cure for HIV. The reservoir consists of viral DNA that survives hidden in the body even after indefinite treatment with antiretrovirals.
Three University of Cape Town (UCT) professors have been elected to stand among South Africa’s leading scholars and scientists as members of the Academy of Science of South Africa (ASSAf), while a UCT associate professor joined the ranks of the South African Young Academy of Science (SAYAS).
A new paper by University of Cape Town (UCT) researchers and their international co-authors has explained why patients experiencing unrelenting epileptic seizures, or status epilepticus, stop responding to first-line medication benzodiazepine.
The 2019 South African Sign Language Interpreting in Higher Education Seminar hosted by the University of Cape Town’s (UCT) Office for Inclusivity and Change (OIC) and Disability Service will take place on campus this month.
On Saturday, 28 September, visitors to the V&A Waterfront passing through the Pier Head square were treated to a truly intriguing sight: a diverse array of dynamic women in white lab coats sharing their scientific research with passers-by.
No two people are alike, so why should their medication be? This is the question that drives the work being done by Professor Collet Dandara and his Pharmacogenomics and Drug Metabolism Research Group (PharmGx) at the University of Cape Town (UCT).